Artwork

A tartalmat a 3DHEALS biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a 3DHEALS vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
Player FM - Podcast alkalmazás
Lépjen offline állapotba az Player FM alkalmazással!

Episode #94 | Advances in Biomaterials for Medical 3D Printing (Virtual Event Recording)

1:45:54
 
Megosztás
 

Manage episode 506628015 series 2901571
A tartalmat a 3DHEALS biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a 3DHEALS vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

What truly makes bioprinting possible isn’t just 3D printers. It's important to understand the materials that flow through them. In this virtual event, we explored the world of biomaterials for tissue engineering and how chemists are shaping the future of regenerative medicine through careful material design.

On demand course: https://3dheals.com/courses/advanced-biomaterials-for-3d-printed-medtech-and-biotech/

YouTube highlights: Here

Our editorial event recap: https://3dheals.com/what-are-the-latest-advances-in-biomaterials-for-3d-bioprinting/

Bowman Bagley, Vice President of Commercial at CollPlant, introduces recombinant human collagen made from genetically modified tobacco plants. This approach avoids animal-derived components while improving performance. The collagen can be concentrated to higher levels and modified more effectively than traditional sources, producing structures that support tissue regeneration while staying printable.

Dr. Janaina Dernowsek, Co-Founder and CEO, takes us inside the Quantis Biotechnology platform, where her team has developed a way to create human extracellular matrix (ECM) from bioprinted tissue constructs. By using dermal-like tissues as bioreactors, they harvest complex protein networks that promote cell growth without triggering inflammation, opening new possibilities for skin regeneration and beyond.

Dr. Riccardo Levato, highlights volumetric bioprinting, a method that uses patterned light to form entire structures within seconds. His team combines material chemistry with advanced design techniques, allowing printers to respond to cellular environments in real time and build vascular networks that support tissue function.

Dr. Jasper Van Hoorick, Co-Founder and CEO of BIO INX, addresses the need for standardization and confronts "biofabrication deception". He describes how his company creates consistent, high-performing materials tailored to specific printing technologies. This work helps make bioprinting more reliable and accessible for researchers worldwide.

Finally, Dr. Scott Taylor, CTO at Poly-Med, discusses absorbable synthetic polymers that provide mechanical support during tissue regeneration and then safely degrade once their job is done.

Whethe

Send us a text

Support the show

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

  continue reading

Fejezetek

1. Introduction to 3D Heals and Biomaterials (00:00:00)

2. Bowman Bagley on Recombinant Human Collagen for Biofabrication (00:02:55)

3. Dr. Janaina Dernowsek on Human ECM Production for Tissue Regeneration (00:21:15)

4. Prof. Riccardo Levato on Volumetric Bioprinting Technologies (00:39:40)

5. Dr. Jasper Van Hoorick on Standardized Bioinks (01:03:09)

6. Dr. Scott Taylor on Absorbable Polymers for Medical Device Printing (01:19:43)

7. Panel Discussion: Future of Biomaterials (01:32:00)

21 epizódok

Artwork
iconMegosztás
 
Manage episode 506628015 series 2901571
A tartalmat a 3DHEALS biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a 3DHEALS vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

What truly makes bioprinting possible isn’t just 3D printers. It's important to understand the materials that flow through them. In this virtual event, we explored the world of biomaterials for tissue engineering and how chemists are shaping the future of regenerative medicine through careful material design.

On demand course: https://3dheals.com/courses/advanced-biomaterials-for-3d-printed-medtech-and-biotech/

YouTube highlights: Here

Our editorial event recap: https://3dheals.com/what-are-the-latest-advances-in-biomaterials-for-3d-bioprinting/

Bowman Bagley, Vice President of Commercial at CollPlant, introduces recombinant human collagen made from genetically modified tobacco plants. This approach avoids animal-derived components while improving performance. The collagen can be concentrated to higher levels and modified more effectively than traditional sources, producing structures that support tissue regeneration while staying printable.

Dr. Janaina Dernowsek, Co-Founder and CEO, takes us inside the Quantis Biotechnology platform, where her team has developed a way to create human extracellular matrix (ECM) from bioprinted tissue constructs. By using dermal-like tissues as bioreactors, they harvest complex protein networks that promote cell growth without triggering inflammation, opening new possibilities for skin regeneration and beyond.

Dr. Riccardo Levato, highlights volumetric bioprinting, a method that uses patterned light to form entire structures within seconds. His team combines material chemistry with advanced design techniques, allowing printers to respond to cellular environments in real time and build vascular networks that support tissue function.

Dr. Jasper Van Hoorick, Co-Founder and CEO of BIO INX, addresses the need for standardization and confronts "biofabrication deception". He describes how his company creates consistent, high-performing materials tailored to specific printing technologies. This work helps make bioprinting more reliable and accessible for researchers worldwide.

Finally, Dr. Scott Taylor, CTO at Poly-Med, discusses absorbable synthetic polymers that provide mechanical support during tissue regeneration and then safely degrade once their job is done.

Whethe

Send us a text

Support the show

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

  continue reading

Fejezetek

1. Introduction to 3D Heals and Biomaterials (00:00:00)

2. Bowman Bagley on Recombinant Human Collagen for Biofabrication (00:02:55)

3. Dr. Janaina Dernowsek on Human ECM Production for Tissue Regeneration (00:21:15)

4. Prof. Riccardo Levato on Volumetric Bioprinting Technologies (00:39:40)

5. Dr. Jasper Van Hoorick on Standardized Bioinks (01:03:09)

6. Dr. Scott Taylor on Absorbable Polymers for Medical Device Printing (01:19:43)

7. Panel Discussion: Future of Biomaterials (01:32:00)

21 epizódok

Minden epizód

×
 
Loading …

Üdvözlünk a Player FM-nél!

A Player FM lejátszó az internetet böngészi a kiváló minőségű podcastok után, hogy ön élvezhesse azokat. Ez a legjobb podcast-alkalmazás, Androidon, iPhone-on és a weben is működik. Jelentkezzen be az feliratkozások szinkronizálásához az eszközök között.

 

Gyors referencia kézikönyv

Hallgassa ezt a műsort, miközben felfedezi
Lejátszás